Physician

Hematology

Dr. Kirk A. Lund, MD

Kirk Lund is an expert in the field of Hematology. He went to University of Utah School of Medicine. He has 1 awards "Meaningful Use Stage 1 Certification". Kirk Lund is also published. He has 1 publication published. The lastest publication: "Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.' He accepts all Medicare patients.

Publications

Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.

Schools

University Of Utah School Of Medicine
University Hospital S Tx Med Center
University Of Ut Med Center

Procedures Preformed

Plasmapheresis
Thoracentesis

Doctors Specialties

Hematology
Oncology

Accepted Insurances

Awards

Meaningful Use Stage 1 Certification

Education

University of Utah
University of Texas Health Science Center
University of Utah School of Medicine

Drug Facts

NPI NUMBER		1881686228
NPPES Provider LastName		LUND
NPPES Provider FirstName		KIRK
NPPES Provider ZIPCode		992042966
NPPES Provider State		WA
Specialty Description		Medical Oncology
Total Claim Count		908.0
Distinct Opioid Count		4.0
Opioid Claim Count		106.0
Percent Opioid Claims		11.67

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1881686228
Last Name Of The Provider	LUND
First Name Of The Provider	KIRK
View All

Similar Doctors

	Dr. Stephen P. Anthony, DO
	Dr. Joe U. Choi, MD This Doctor is OpenDoctor Recommended.
	Dr. Arvind Chaudhry, MD This Doctor is OpenDoctor Recommended.
	Dr. Kawal D. Chester, MD This Doctor is OpenDoctor Recommended.
	Dr. Corliss L. Newman, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert H. Gersh, MD
	Dr. Mei Dong, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey T. Bunning, MD
	Dr. Howard D. Stang, MD This Doctor is OpenDoctor Recommended.